Selenium and lung cancer: A quantitative analysis of heterogeneity in the current epidemiological literature

Cancer Epidemiology Biomarkers and Prevention

Volumn 13, Issue 5, 2004, Pages 771-778

  Zhuo, Hanjing ^a   Smith, Allan H ^a   Steinmaus, Craig ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SELENIUM;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER RISK; CARCINOGENESIS; CELL HETEROGENEITY; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET; DIETARY INTAKE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EXPOSURE; EPIDEMIOLOGICAL DATA; FEMALE; HUMAN; LUNG CANCER; MALE; META ANALYSIS; NAIL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SMOKING; SYSTEMATIC REVIEW;

CALIFORNIA; CONFIDENCE INTERVALS; DIETARY SUPPLEMENTS; FEMALE; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; NAILS; PROBABILITY; PROGNOSIS; REFERENCE VALUES; RISK ASSESSMENT; SELENIUM; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 2942610569     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 1999;83:18-29.
2. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999;80:827-41.
3. Albert R, Spiro S, Jett J. Lung tumor. In: Khan M, Almond G, Maia F, editors. Comprehensive respiratory medicine. London: Harcourt Brace and Co. Ltd.; 1999;43:1-24.
4. National Research Council. Food and Nutrition Board. Recommended dietary allowances. Washington, DC: National Academy Press; 1989.
5. Ip C, Dong Y, Ganther HE. New concepts in selenium chemoprevention. Cancer Metastasis Rev 2002;21:281-9.
6. Shamberger R, Tytko SA, Willis CE. Antioxidants and cancer. Part VI. Selenium and age-adjusted human cancer mortality. Arch Environ Health 1976;31:231-5.
7. Schrauzer GN, White DA, Schneider CJ. Cancer mortality correlation studies-IV: associations with dietary intakes and blood levels of certain trace elements, notably Se-antagonists. Bioinorg Chem 1977;7:35-56.
8. Clark LC, Cantor KP, Allaway WH. Selenium in forage crops and cancer mortality in U.S. counties. Arch Environ Health 1991;46:37-42.
9. Duffield-Lillico AJ, Dalkin BL, Reid ME, et al. Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial. BJU Int 2003;91:608-12.
10. Rudolph RE, Vaughan TL, Kristal AR, et al. Serum selenium levels in relation to markers of neoplastic progression among persons with Barrett's esophagus. J Natl Cancer Inst 2003;95:750-7.
11. Comstock GW, Alberg AJ, Huang HY, et al. The risk of developing lung cancer associated with antioxidants in the blood: ascorbic acid, carotenoids, α-tocopherol, selenium, and total peroxyl radical absorbing capacity. Cancer Epidemiol Biomarkers & Prev 1997;6:907-16.
12. Kabuto M, Imai H, Yonezawa C, et al. Prediagnostic serum selenium and zinc levels and subsequent risk of lung and stomach cancer in Japan. Cancer Epidemiol Biomarkers & Prev 1994;3:465-9.
13. Knekt P, Marniemi J, Teppo L, Heliovaara M, Aromaa A. Is low selenium status a risk factor for lung cancer? Am J Epidemiol 1998;148:975-82.
14. Menkes MS, Comstock GW, Vuilleumier JP, Helsing KJ, Rider AA, Brookmeyer R. Serum β-carotene, vitamins A and E, selenium, and the risk of lung cancer. N Engl J Med 1986;315:1250-4.
15. Nomura A, Heilbrun LK, Morris JS, Stemmermann GN. Serum selenium and the risk of cancer, by specific sites: case-control analysis of prospective data. J Natl Cancer Inst 1987;79:103-8.
16. Salonen JT, Alfthan G, Huttunen JK, Puska P. Association between serum selenium and the risk of cancer. Am J Epidemiol 1984;120:342-9.
17. Salonen JT, Salonen R, Lappetelainen R, Maenpaa PH, Alfthan G, Puska P. Risk of cancer in relation to serum concentrations of selenium and vitamins A and E: matched case-control analysis of prospective data. Br Med J (Clin Res Ed) 1985;290:417-20.
18. van den Brandt PA, Goldbohm RA, van't Veer P, et al. A prospective cohort study on selenium status and the risk of lung cancer. Cancer Res 1993;53:4860-5.
19. Goodman GE, Schaffer S, Bankson DD, Hughes MP, Omenn GS. Predictors of serum selenium in cigarette smokers and the lack of association with lung and prostate cancer risk. Cancer Epidemiol Biomarkers & Prev 2001;10:1069-76.
20. Clark LC, Combs GF, Turnbull BW, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin: a randomized controlled trial. JAMA 1996;276:1657-71.
21. Reid ME, Duffield-Lillico AJ, Garland L, Tumbull BW, Clark LC, Marshall JR. Selenium supplementation and lung cancer incidence: an update of the Nutritional Prevention of Cancer Trial. Cancer Epidemiol Biomarkers & Prev 2002;11:1285-91.
22. Broghamer WL. Relationship between serum selenium levels and patients with carcinoma. Cancer 1976;37:1384-8.
23. Hu J, Johnson K, Mao Y, et al. A case-control study of diet and lung cancer in northeast China. Int J Cancer 1997;71:924-31.
24. Kromhout D. Essential micronutrients in relation to carcinogenesis. Am J Clin Nutr 1987;45:1361-7.
25. Zhou B, Wang T, Sun G, Guan P, Wu JM. A case-control study of the relationship between dietary factors and risk of lung cancer in women of Shenyang, China. Oncol Rep 1999;6:139-43.
26. Knekt P, Aromaa A, Maatela J, et al. Serum selenium and subsequent risk of cancer among Finnish men and women. J Natl Cancer Inst 1990;82:864-8.
27. Knekt P. Vitamin E and smoking and the risk of lung cancer. Ann NY Acad Sci 1993;686:280-7; discussion 287-8.
28. Combs GF, Clark LC, Tumbull BW. Reduction of cancer risk with an oral supplement of selenium. Biomed Environ Sci 1997;10:227-34.
29. Duffield-Lillico AJ, Reid ME, Tumbull BW, et al. Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial. Cancer Epidemiol Biomarkers & Prev 2002;11:630-9.
30. Greenland S. Meta-analysis. In: Rothman KJ, Greenland S, editors. Modern epidemiology. Philadelphia: Lippincott-Raven; 1998;643-73.
31. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
32. Petitti D. Meta-analysis, decision analysis and cost-effectiveness analysis: methods for quantitative synthesis in medicine. New York: Oxford University Press; 1994.
33. Shore RE, Gardner MJ, Pannett B. Ethylene oxide: an assessment of the epidemiological evidence on carcinogenicity. Br J Ind Med 1993;50:971-97.
34. Light RJ, Pillemar DB. Summing up: the science of reviewing research. Cambridge, MA: Harvard University Press; 1984.
35. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple graphical test. Br Med J 1997;315:629-34.
36. Begg CB. Publication bias. In: Cooper H, Hedges LV, editors. Handbook of research synthesis. New York: Russell Sage Foundation; 1994. p. 399-409.
37. Ratnasinghe D, Tangrea JA, Forman MR, et al. Serum tocopherols, selenium and lung cancer risk among tin miners in China. Cancer Causes & Control 2000;11:129-35.
38. Virtamo J, Valkeila E, Alfthan G, Punsar S, Huttunen J, Karvomen M. Serum selenium and risk of cancer: a prospective follow-up of nine years. Cancer 1987;60:145-8.
39. Garland M, Morris JS, Stampfer MJ, et al. Prospective study of toenail selenium levels and cancer among women. J Natl Cancer Inst 1995;87:497-505.
40. Hartman TJ, Taylor PR, Alfthan G, et al. Toenail selenium concentration and lung cancer in male smokers (Finland). Cancer Causes & Control 2002;13:923-8.
41. Peleg I, Morris S, Hames CG. Is serum selenium a risk factor for cancer? Med Oncol Tumor Pharmacother 1985;2:157-63.
42. Levander OA. The need for measures of selenium status. J Am Coll Toxicol 1986;5:37-44.
43. Morris S, Stampfer MJ, Willett WC. Dietary selenium in humans: toenails as an indicator. Biol Trace Elem Res 1983;5:529-37.
44. Hunter DJ, Morris JS, Chute CG, et al. Predictors of selenium concentration in human toenails. Am J Epidemiol 1990;132:114-22.
45. Longnecker MP, Stram DO, Taylor PR, et al. Use of selenium concentration in whole blood, serum, toenails, or urine as a surrogate measure of selenium intake. Epidemiology 1996;7:384-90.
46. Longnecker MP, Taylor PR, Levander OA, et al. Selenium in diet, blood, and toenails in relation to human health in a seleniferous area. Am J Clin Nutr 1991;53:1288-94.
47. Swanson CA, Longnecker MP, Veillon C, et al. Selenium intake, age, gender, and smoking in relation to indices of selenium status of adults residing in a seleniferous area. Am J Clin Nutr 1990;52:858-62.
48. Longnecker MP, Stampfer MJ, Morris JS, et al. A 1-y trial of the effect of high-selenium bread on selenium concentrations in blood and toenails. Am J Clin Nutr 1993;57:408-13.
49. Garland M, Morris JS, Rosner BA, et al. Toenail trace element levels as biomarkers: reproducibility over a 6-year period. Cancer Epidemiol Biomarkers & Prev 1993;2:493-7.
50. World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition and the prevention of cancer: a global perspective. Washington, DC: American Institute for Cancer Research; 1997.
51. Burk RF, Levander OA. Selenium. In: Shills ME, Olson JA, Shike M, Ross AC, editors. Modern nutrition in health and disease. Baltimore: Williams & Wilkins; 1999:265-76.
52. Fontham ET, Pickle LW, Haenszel W, Correa P, Lin YP, Falk RT. Dietary vitamins A and C and lung cancer risk in Louisiana. Cancer 1988;62:2267-73.
53. Dorgan JF, Ziegler RG, Schoenberg JB, et al. Race and sex difference in associations of vegetables, fruits, and carotenoids with lung cancer risk in New Jersey (United States). Cancer Causes & Control 1993;4:273-81.
54. Voorrips LE, Goldbohm RA, Verhoeven DT, et al. Vegetables and fruit consumption and lung cancer risk in the Netherlands Cohort Study on diet and cancer. Cancer Causes & Control 2000;11:101-15.
55. Luty-Frackiewicz A, Jethon Z, Januszewska L. Effect of smoking and alcohol consumption on the serum selenium level of lower Silesian population. Sci Total Environ 2002;285:89-95.
56. Willett WC, Polk BF, Morris JS, et al. Prediagnostic serum selenium and risk of cancer. Lancet 1983;2:130-4.
57. Trobs M, Renner T, Scherer G, et al. Nutrition, antioxidants, and risk factor profile of nonsmokers, passive smokers and smokers of the Prevention Education Program (PEP) in Nuremberg, Germany. Prev Med 2002;34:600-7.
58. Feskanich D, Ziegler RG, Michaud DS, et al. Prospective study of fruit and vegetable consumption and risk of lung cancer among men and women. J Natl Cancer Inst 2000;92:1812-3.
59. Marshall JR, Hastrup JL. Mismeasurement and the resonance of strong confounders: uncorrelated errors. Am J Epidemiol 1996;143:1069-78.
60. Stram DO, Huberman M, Wu AH. Is residual confounding a reasonable explanation for the apparent protective effects of β-carotene found in epidemiologic studies of lung cancer in smokers? Am J Epidemiol 2002;155:622-8.
61. van den Brandt PA, Goldbohm RA, van't Veer P, Bode P, Hermus RJ, Sturmans F. Predictors of toenail selenium levels in men and women. Cancer Epidemiol Biomarkers & Prev 1993;2:107-12.
62. Ames BN. Dietary carcinogens and anticarcinogens. Science 1983;221:1256-64.
63. Thornton A, Lee P. Publication bias in meta-analysis: its causes and consequences. J Clin Epidemiol 2000;53:207-16.
64. Coates RJ, Weiss NS, Daling JR, Morris JS, Labbe RF. Serum levels of selenium and retinol and the subsequent risk of cancer. Am J Epidemiol 1988;128:515-23.
65. Criqui MH, Bangiwala S, Goodman DS, et al. Selenium, retinol, retinol-binding protein and uric acid. Association with cancer mortality in a population-based prospective case-control study. Ann Epidemiol 1991;1:385-93.
66. Ringstad J, Jacobsen BK, Stretli S, Thomassen Y. Serum selenium concentration associated with risk of cancer. J Clin Pathol 1988;41:454-7.